Thursday, January 29, 2015
Amerita, Inc., a wholly owned subsidiary of PharMerica Corporation (NYSE:PMC), today announced that it has completed the acquisition of Coastal Pharmaceutical Services Corporation, d/b/a InfusionRx (“InfusionRx”). Financial terms of the transaction were not disclosed.
InfusionRx provides a complete range of home infusion and pharmacy services, including home infusion therapies, pain management, nutritional therapies, and specialty pharmacy services. The company serves patients in their homes, doctors’ offices, and other non-hospital settings.
“This is an important milestone for both Amerita and PharMerica,” said Greg Weishar, PharMerica’s Chief Executive Officer. “InfusionRx advances Amerita’s market breadth and is consistent with our strategy to drive growth through acquisitions. We will remain disciplined and opportunistic in our pursuit of acquisitions to drive shareholder value.”
Jim Glynn, Chief Executive Officer of Amerita, said, “We are pleased to welcome InfusionRx to our company. InfusionRx is a leader in Southern California, and InfusionRx will draw on Amerita’s scale and operational expertise to further bolster its specialty infusion capabilities in the greater Los Angeles area, the country’s second largest market. We will continue to provide exemplary service across our growing service platform to exceed the expectations of our customers and patients.”
May Kuo Barry, a founder of InfusionRx said, “In Amerita, we have found an ideal partner. Like InfusionRx, Amerita adheres to the highest standards for patient care and delivers a superior pharmacy experience. We look forward to working with Amerita to ensure a smooth transition and to realizing the significant benefits that this transaction will bring to our patients, providers and employees.”
Source : http://www.businesswire.com/
